Chargement en cours...

Ageing is a risk factor in imatinib mesylate cardiotoxicity

AIMS: Chemotherapy-induced heart failure is increasingly recognized as a major clinical challenge. Cardiotoxicity of imatinib mesylate, a highly selective and effective anticancer drug belonging to the new class of tyrosine kinase inhibitors, is being reported in patients, some progressing to conges...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur J Heart Fail
Auteurs principaux: Maharsy, Wael, Aries, Anne, Mansour, Omar, Komati, Hiba, Nemer, Mona
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Ltd 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4238824/
https://ncbi.nlm.nih.gov/pubmed/24504921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.58
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!